(Q39527930)

12 September 2017

title

Apoptosis induction through proteasome inhibitory activity of cucurbitacin D in human T-cell leukemia (English)

1 reference

12 September 2017

1 reference

Ning Ding

1

1 reference

12 September 2017

Uki Yamashita

2

1 reference

12 September 2017

Hidetada Matsuoka

3

1 reference

12 September 2017

Tsutomu Sugiura

4

1 reference

12 September 2017

Junichi Tsukada

5

1 reference

12 September 2017

Junko Noguchi

6

1 reference

12 September 2017

Yasuhiro Yoshida

7

1 reference

12 September 2017

language of work or name

English

0 references

publication date

23 December 2010

1 reference

12 September 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

Cancer

1 reference

12 September 2017

volume

117

1 reference

12 September 2017

issue

12

1 reference

12 September 2017

page(s)

2735-2746

1 reference

New therapeutic approaches for adult T-cell leukaemia

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

Anticancer and antiinflammatory activities of cucurbitacins from Cucurbita andreana

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

Cucurbitacins and cucurbitane glycosides: structures and biological activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

Cucurbitacin D isolated from Trichosanthes kirilowii induces apoptosis in human hepatocellular carcinoma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

Emerging roles of caspase-3 in apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

NF-kappaB at the crossroads of life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

The proteasome: a suitable antineoplastic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

Differential bortezomib sensitivity in head and neck cancer lines corresponds to proteasome, nuclear factor-kappaB and activator protein-1 related mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

Efficacy and mechanism of action of the proteasome inhibitor PS-341 in T-cell lymphomas and HTLV-I associated adult T-cell leukemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

The proteasome and proteasome inhibitors in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

Histone deacetylases and cancer: causes and therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl+ cells sensitive and resistant to STI571.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

NPI-0052, a novel proteasome inhibitor, induces caspase-8 and ROS-dependent apoptosis alone and in combination with HDAC inhibitors in leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

DNA-binding activity of NF-kappaB and phosphorylation of p65 are induced by N-acetylcysteine through phosphatidylinositol (PI) 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

Interleukin 1 Activates STAT3/Nuclear Factor-κB Cross-talk via a Unique TRAF6- and p65-dependent Mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

Proteasome inhibitor, bortezomib, potently inhibits the growth of adult T-cell leukemia cells both in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

BCL-xL regulates synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

NIK-333 inhibits growth of human T-cell leukemia virus type I-infected T-cell lines and adult T-cell leukemia cells in association with blockade of nuclear factor-kappaB signal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

Anti-adult T-cell leukemia effects of brown algae fucoxanthin and its deacetylated product, fucoxanthinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

IkappaB kinases: key regulators of the NF-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

Induction of cell cycle arrest and apoptosis by the proteasome inhibitor PS-341 in Hodgkin disease cell lines is independent of inhibitor of nuclear factor-kappaB mutations or activation of the CD30, CD40, and RANK receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

The proteasome: a novel target for cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

A heterodimeric complex that promotes the assembly of mammalian 20S proteasomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

Inhibition of nitric oxide generation by 23,24-dihydrocucurbitacin D in mouse peritoneal macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

Interactions between bortezomib and romidepsin and belinostat in chronic lymphocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

Aggresome induction by proteasome inhibitor bortezomib and alpha-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

A signal network involving coactivated NF-kappaB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

inferred from DOI database lookup

7 January 2021

based on heuristic

Forging a proteasome alpha-ring with dedicated proteasome chaperones

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25711

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.25711

1 reference

12 September 2017

1 reference